Antiverse raises $9.3M Series A to develop antibodies for undruggable disease targets, led by Soulmates Ventures.
Amount Raised
$9.3 Million
Round Type
Series A
CardiffBiotechnologyHealth CareTherapeuticsInvestors
Description
Antiverse, an AI-driven techbio company, has announced the close of a $9.3 million Series A financing. The funding will support expansion of its AI antibody design platform and accelerate the development of its therapeutic pipeline. The round was led by Soulmates Ventures, with participation from several existing investors. Additionally, Antiverse has entered into a research agreement with the Cystic Fibrosis Foundation.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Antiverse that raised within 45 days of this round, from Fundz verified event records.
- STORM Therapeutics raised $56M (Series C) on April 16, 2026.
- Beeline Medicines raised $300M (Series A) on April 16, 2026.
- Sparian Biosciences raised $15M (Grant) on April 13, 2026.
- Sidewinder Therapeutics raised $137M (Series B) on April 8, 2026.
- Marvel Biosciences raised an undisclosed amount (Funding Round) on April 7, 2026.
- TransCode Therapeutics raised $20M (Funding Round) on April 7, 2026.
Who to call at Antiverse, and when
A new round usually means Antiverse is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Antiverse raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Antiverse, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Antiverse. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Antiverse raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAntiverse raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.